Finance

Beta
Lists
IUI1:FRA
Intuitive Surgical Inc
€302.65
-13.75%
(-48.25) 1D
Jul 17, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for IUI1...
Open
€317.00
High
€317.95
Low
€302.65
Mkt. cap
122.33B
Avg. vol.
73.00
Volume
327.00
52-wk high
€512.10
52-wk low
€302.65
No. of employees
17K
Open
€317.00
High
€317.95
Low
€302.65
Mkt. cap
122.33B
Avg. vol.
73.00
Volume
327.00
52-wk high
€512.10
52-wk low
€302.65
No. of employees
17K
News stories
From sources across the web
Profile
Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world. Intuitive Surgical first appeared on the Fortune 500 in 2024 at number 497; in 2025 the company rose to number 459 overall and ranked 43rd within the healthcare sector. Wikipedia
About Intuitive Surgical Inc
CEODavid J. Rosa
Employees17K
Founded1995
HeadquartersSunnyvale, California, United States
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.51B
2.87B
2.77B
2.89B
Cost of goods sold
842.70M
961.90M
940.30M
927.80M
Cost of revenue
842.70M
961.90M
940.30M
927.80M
Research and development expenses
329.40M
352.90M
361.90M
370.60M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
573.30M
687.10M
613.30M
617.90M
Operating expense
902.70M
1.04B
975.20M
988.50M
Total operating expenses
1.75B
2.00B
1.92B
1.92B
Operating income
759.70M
864.30M
855.30M
976.00M
Other non operating income
-
-
-
-
EBT including unusual items
855.20M
955.60M
940.40M
1.05B
EBT excluding unusual items
855.20M
950.90M
939.80M
1.06B
Income tax expense
146.00M
156.10M
114.40M
231.40M
Effective tax rate
17.07%
16.34%
12.16%
21.94%
Other operating expenses
-
-
-
-
Net income
704.40M
794.80M
821.50M
818.10M
Net profit margin
28.12%
27.73%
29.65%
28.29%
Earnings per share
2.40
2.53
2.50
2.80
Interest and investment income
82.30M
77.50M
85.70M
82.70M
Interest expense
-
-
-
-
Net interest expenses
82.30M
77.50M
85.70M
82.70M
Depreciation and amortization charges
-
-
-
-
EBITDA
919.70M
1.02B
1.06B
1.18B
Gain or loss from assets sale
-
13.70M
-7.90M
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more